期刊文献+

血清睾酮水平与前列腺癌发生和进展的相关性探讨 被引量:2

The Relevance of Serum Testosterone Level to the Occurrence and Progression of Prostate Cancer
下载PDF
导出
摘要 前列腺癌(prostate cancer,PCa)是一种世界范围内发病率极高的恶性肿瘤,Huggins最初认为血清睾酮(testosterone,T)的升高会增加患前列腺癌的风险,但现在越来越多的研究表明与血清睾酮水平与前列腺癌的发病风险、病理分期、术后评估有着相当复杂的相关性。近年来,我国前列腺癌的发病率一直呈上升的趋势,虽然血清睾酮水平与前列腺癌之间的联系已建立,但血清睾酮水平与前列腺癌的关系的病理机制尚没有统一的说法,其确切的病理生理机制仍不清楚。本文主要从发病风险,病理分期和术后评估等方面对血清睾酮水平与前列腺癌发生和进展的相关性进行综述。 Prostate cancer is a malignant tumor with a very high incidence worldwide. Huggins initially believed that increased serum testosterone level would increase the risk of prostate cancer, but now more and more studies have shown a rather complicated correlation between serum testosterone level and the risk of prostate cancer,pathological staging, and postoperative evaluation. In recent years, the incidence of prostate cancer in China has been on the rise. Although the relationship between serum testosterone level and prostate cancer has been established,there is still no unified statement on the pathological mechanism of the relationship between serum testosterone level and prostate cancer, and the exact pathophysiological mechanism remains unclear. In this article, the role of serum testosterone levels in the diagnosis and treatment of prostate cancer was reviewed from the perspectives of risk,pathological staging and postoperative evaluation.
作者 龙鑫淼 钟淑芳 王江 张文君 李勇 李卿 LONG Xin-miao;ZHONG Shu-fang;WANG Jiang;ZHANG Wen-jun;LI Yong;LI Qing(Institute of Integrative medicine,Xiangnan University,Chenzhou,Hunan 423000;Institute of medical imaging and laboratory,Xiangnan University,Chenzhou,Hunan 423000;Clinical College,Affiliated Hospital of Xiangnan University,Institute of Integrative medicine,Chenzhou Hunan 423000)
出处 《智慧健康》 2019年第31期49-51,64,共4页 Smart Healthcare
关键词 前列腺癌 睾酮 病理分级 Prostate cancer Testosterone Pathology grade
  • 相关文献

参考文献4

二级参考文献45

  • 1李江源,李小鹰,李明,张高魁,马芳玲,刘志明,张南雁,孟萍.血清游离睾酮水平和睾酮分泌指数随年龄老化而降低[J].中华男科学杂志,2006,12(6):555-558. 被引量:46
  • 2李江源.迟发性睾丸功能减退的筛查、诊断、治疗和监测[J].中国男科学杂志,2007,21(5):69-71. 被引量:7
  • 3Isom-Batz G,Bianco FJ Jr,Kattan MW,et al.Testosterone as a predictor of pathological stage in clinically localized prostate cancer.J Urol 2005; 173(6):1935-1937.
  • 4Walsh PC.Campbell's Urology,8th ed.Philadelphia:Saunders,2002:3003-11,3056,3094-3095.
  • 5Kattan MW,Wheeler TM,Scardino PT.Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.J Clin Oncol 1999; 17(5):1499-1507.
  • 6Hoffman MA,DeWolf WC,Morgentaler A.Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000; 163(3):824-827.
  • 7Massengill JC,Sun L,Moul JW,et al.Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy.J Urol 2003; 169(5):1670-1675.
  • 8Lokeshwar BL,Hurkadli KS,Sheth AR,et al.Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma,the Dunning R3327G rat tumor.Cancer Res 1993; 53 (20):4855-4859.
  • 9Zhang PL,Rosen S,Veeramachaneni R,et al.Association between prostate cancer and serum testosterone levels.Prostate 2002; 53(3):179-182.
  • 10Kattan MW,Eastham JA,Stapleton AM,et al.A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.J Natl Cancer Inst 1998; 90(10):766-771.

共引文献22

同被引文献27

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部